Immunovirotherapy showed acceptable adverse-event profile in pediatric high-grade gliomas | 2 Minute Medicine
2 Minute Medicine ,
1. Treatment with herpes simplex virus type 1 oncolytic virotherapy was shown not to demonstrate serious adverse events in…